Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Plans Guidance This Year On Co-Development Of Diagnostics And Drugs

This article was originally published in The Gray Sheet

Executive Summary

FDA expects to complete a guidance document on co-development of diagnostics and drugs used for personalized medicine by the end of this year, FDA Commissioner Margaret Hamburg said at a meeting in Washington, D.C., Feb. 25

You may also be interested in...



New J&J Drug Candidates Don't Go It Alone: Companion Dx Are Standard

Johnson & Johnson's drug business could be a particularly productive partnering site for molecular diagnostics firms over the next several years, statements from one company executive suggest

New J&J Drug Candidates Don't Go It Alone: Companion Dx Are Standard

Johnson & Johnson's drug business could be a particularly productive partnering site for molecular diagnostics firms over the next several years, statements from one company executive suggest

New J&J Drug Candidates Don't Go It Alone: Companion Dx Are Standard

The drug giant is trying to partner with assay technology makers as early as possible in the development cycle, Centocor VP-biomarkers Dracopoli said at BIO.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT028551

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel